The Fifty-Three Annual General Meeting (AGM) of the Company will be held on Wednesday, 25th June 2025 at 3.00 p.m. at Sambava Chambers, 4th Floor, Sir. P. M. Road, Fort, Mumbai: 400001. Pursuant ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Triochem Products Ltd has informed the BSE that its 53rd Annual General Meeting will be held on Wednesday, June 25, 2025, at 3:00 PM at the registered office in Sambava Chambers, Fort, Mumbai. The company has submitted its Annual Report for FY 2024-25 along with the AGM Notice under Regulation 34 of SEBI Listing Regulations. Shareholders will vote on eight items including adoption of FY25 financial statements, re-appointment of two directors (Mr. Rajesh R. Deora and 88-year-old Mr. Ramu S. Deora), appointment of two new Independent Directors (Mr. Shailendra Mishra and Mr. Vipul Desai) for 5-year terms starting March 29, 2025, ratification of secretarial auditors, and approval of related-party transactions with group entities. The related-party transactions include sale/purchase limits of up to Rs. 60 crore each with G Amphray Laboratories (Proprietorship and Partnership firms) and Rs. 15-20 crore each with Amphray Pharmaceuticals Pvt Ltd, Triochem Laboratories Pvt Ltd, and Ambernath Plasto Packaging Pvt Ltd. Remote e-voting runs from June 22-24, 2025, with the cut-off date set as June 18, 2025, and book closure from June 19-25, 2025.
This is a routine procedural filing for the upcoming AGM and does not directly affect stock price. However, the combined related-party transaction limits exceeding Rs. 100 crore annually signal significant inter-group business activity, which shareholders should review. The continuation of the 88-year-old Chairman as director requires a special resolution, so investors should watch the voting outcome.